X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
1.600
-0.080 (-4.76%)
At close: Aug 1, 2025, 4:00 PM
1.630
+0.030 (1.87%)
After-hours: Aug 1, 2025, 7:30 PM EDT
R1 RCM Market Cap
X4 Pharmaceuticals has a market cap or net worth of $9.26 million as of August 1, 2025. Its market cap has decreased by -92.57% in one year.
Market Cap
9.26M
Enterprise Value
351.90K
1-Year Change
-92.57%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has decreased from $101.77M to $9.26M, a decrease of -90.90%. That is a compound annual growth rate of -31.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 9.26M | -92.60% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | 104.72M | -39.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |